Cite
HARVARD Citation
Meric-Bernstam, F. et al. (n.d.). CBX-12-101: A first-in-human study of CBX-12, an alphalex peptide drug conjugate (PDC) in patients with advanced or metastatic solid tumors. European journal of cancer. pp. S7-S8. [Online].